Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Kammertöns, Thomas Dr. (2) Kettenmann, Helmut Prof. Dr. (2) Lorenz, Felix Dr. (3) Poncette, Lucia (1) Uckert, Wolfgang Prof. Dr. (18) (-) Blankenstein, Thomas Prof. Dr. (7) (-) Gavvovidis, Ioannis Dr. (1) (-) Leisegang, Matthias Dr. (5) (-) Obenaus, Matthias (1) (-) Rhein, Simone Dr. (2) Bioinformatics (1) Biologie maligner Lymphome (19) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Molekulare Immunologie und Gentherapie (24) (-) Molekulare Zellbiologie und Gentherapie (10) Proteom Dynamik (1) Signaltransduktion in Tumorzellen (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) Translationale Onkologie solider Tumore (1) 1998 (2) 2000 (2) 2003 (4) 2004 (1) 2005 (3) 2006 (2) (-) 2007 (2) (-) 2008 (2) 2010 (4) (-) 2011 (2) 2012 (3) 2013 (2) 2014 (4) (-) 2015 (3) 2016 (5) 2017 (3) 2018 (1) (-) 2019 (1) 2021 (1) 2022 (1) 10 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Gavvovidis, Ioannis Dr.Leisegang, Matthias Dr.Obenaus, MatthiasRhein, Simone Dr.Molekulare Zellbiologie und Gentherapie20072008201120152019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 02. Januar 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein 01. Juni 2015 in BIOspektrum Designer T cells - New possibilities for immunotherapy of cancer [Designer-T-Zellen - neue Möglichkeiten für die Immuntherapie von Krebs] M. Leisegang W. Uckert 01. April 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein 28. Juli 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 15. Januar 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 01. Mai 2008 in J Mol Med Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette M. Leisegang B. Engels P. Meyerhuber E. Kieback D. Sommermeyer S.A. Xue S. Reuss H. Stauss W. Uckert 15. Januar 2008 in Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert 15. Oktober 2007 in J Immunol Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity M. Weinhold D. Sommermeyer W. Uckert T. Blankenstein 01. April 2007 in Gene Ther Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles S. Reuss P. Biese F.L. Cosset Y. Takeuchi W. Uckert
02. Januar 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein
01. Juni 2015 in BIOspektrum Designer T cells - New possibilities for immunotherapy of cancer [Designer-T-Zellen - neue Möglichkeiten für die Immuntherapie von Krebs] M. Leisegang W. Uckert
01. April 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
28. Juli 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
15. Januar 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
01. Mai 2008 in J Mol Med Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette M. Leisegang B. Engels P. Meyerhuber E. Kieback D. Sommermeyer S.A. Xue S. Reuss H. Stauss W. Uckert
15. Januar 2008 in Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
15. Oktober 2007 in J Immunol Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity M. Weinhold D. Sommermeyer W. Uckert T. Blankenstein
01. April 2007 in Gene Ther Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles S. Reuss P. Biese F.L. Cosset Y. Takeuchi W. Uckert
